Last reviewed · How we verify
ET-STEM
At a glance
| Generic name | ET-STEM |
|---|---|
| Sponsor | Samsung Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- MODELING OBSESSIVE COMPULSIVE DISORDER AND EXPLORING TREATMENT RESPONSE USING INNOVATIVE THERAPIES AND STEM CELLS (NA)
- BAPS in Botswana: The Thotloetso Trial (NA)
- The Lumbar Interbody Fusion vs. Multidisciplinary Rehabilitation (LIFEHAB) Trial (NA)
- Mandala Intervention on Mother-Infant Bonding and Parenting Self-Efficacy After Negative Birth Experiences (NA)
- Movement Imitation Therapy for Preterm Babies (MIT-PB) - A Pilot Study (NA)
- VCOM Pain Free Research Collaborative (NA)
- Personalised Process-based Psychological Interventions for Paediatric Headaches (NA)
- Ultrasound-Guided Erector Spinae Plane Block Versus Intravenous Nalbuphine (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ET-STEM CI brief — competitive landscape report
- ET-STEM updates RSS · CI watch RSS
- Samsung Medical Center portfolio CI